Cargando…

Comparison of commercial SARS-CoV-2 surrogate neutralization assays with a full virus endpoint dilution neutralization test in two different cohorts

Determination of neutralizing antibody titers is still considered the gold standard for infection protection. A full virus neutralization test (VNT) with replication-competent, infectious SARS-CoV-2, is labor-intensive and requires Biosafety Level 3 certified laboratories. Therefore, several commerc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adams, Ortwin, Andrée, Marcel, Hermsen, Derik, Lübke, Nadine, Timm, Jörg, Schaal, Heiner, Müller, Lisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier B.V. 2022
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212436/ https://www.ncbi.nlm.nih.gov/pubmed/35724697 http://dx.doi.org/10.1016/j.jviromet.2022.114569

Ejemplares similares

Sensitivity of anti-SARS-CoV-2 serological assays in a high-prevalence setting
por: Müller, Lisa, et al.
Publicado: (2021)

Considerations for the Feasibility of Neutralizing Antibodies as a Surrogate Endpoint for COVID-19 Vaccines
por: Liu, Jianyang, et al.
Publicado: (2022)

Extraction-free SARS-CoV-2 detection by rapid RT-qPCR universal for all primary respiratory materials
por: Lübke, Nadine, et al.
Publicado: (2020)

Surrogate endpoints.
por: Ellenberg, S. S.
Publicado: (1993)

The evaluation of surrogate endpoints
por: Burzykowski, Tomasz, et al.
Publicado: (2005)

Surrogate Endpoints in Medicine
por: Srivastava, Sudhir, et al.
Publicado: (2002)

Homogeneous surrogate virus neutralization assay to rapidly assess neutralization activity of anti-SARS-CoV-2 antibodies
por: Kim, Sun Jin, et al.
Publicado: (2022)

Towards climate neutrality for household energy consumption
por: Renn, Ortwin
Publicado: (2022)

Neutral theory: applicability and neutrality of clinical study endpoints where a disease-specific instrument is available
por: Jandhyala, Ravi
Publicado: (2023)

Development of a Surrogate Neutralization Assay for Norovirus Vaccine Evaluation at the Cellular Level
por: Wang, Xiaoli, et al.
Publicado: (2018)

Evaluation of Cell-Based and Surrogate SARS-CoV-2 Neutralization Assays
por: Sholukh, Anton M., et al.
Publicado: (2021)

The Search for Surrogate Endpoints in Trials in Diffuse Large B‐Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project
por: Sargent, Daniel J., et al.
Publicado: (2017)

Adjusted COVID-19 booster schedules balance age-dependent differences in antibody titers benefitting risk populations
por: Müller, Lisa, et al.
Publicado: (2022)

Immune response to third SARS‐CoV‐2 vaccination in seronegative kidney transplant recipients: Possible improvement by mycophenolate mofetil reduction
por: Kantauskaite, Marta, et al.
Publicado: (2022)

Validation and Establishment of the SARS-CoV-2 Lentivirus Surrogate Neutralization Assay as a Prescreening Tool for the Plaque Reduction Neutralization Test
por: Merluza, John, et al.
Publicado: (2023)

A simple protein-based surrogate neutralization assay for SARS-CoV-2
por: Abe, Kento T., et al.
Publicado: (2020)

An Assessment of Serological Assays for SARS-CoV-2 as Surrogates for Authentic Virus Neutralization
por: Wohlgemuth, Nicholas, et al.
Publicado: (2021)

Overview of Biomarkers and Surrogate Endpoints in Drug Development
por: Wagner, John A.
Publicado: (2002)

Is critical care ready for an economic surrogate endpoint?
por: Wilcox, M Elizabeth, et al.
Publicado: (2015)

Surrogate endpoints in early prostate cancer research
por: Williams, Scott
Publicado: (2018)

Surrogate endpoints… Uncommon for a common man!
por: Kumar, Ashish
Publicado: (2019)

Surrogate Endpoints for Late Kidney Transplantation Failure
por: Naesens, Maarten, et al.
Publicado: (2022)

Detection of SARS-CoV-2 Antibodies: Comparison of Enzyme Immunoassay, Surrogate Neutralization and Virus Neutralization Test
por: Vilibic-Cavlek, Tatjana, et al.
Publicado: (2023)

A Multivariant Surrogate Neutralization Assay Identifies Variant-Specific Neutralizing Antibody Profiles in Primary SARS-CoV-2 Omicron Infection
por: Springer, David Niklas, et al.
Publicado: (2023)

Need for better reporting of trials with surrogate endpoints: SPIRIT|CONSORT-SURROGATE extensions
por: Ciani, Oriana, et al.
Publicado: (2022)

A neutralization assay for respiratory syncytial virus using a quantitative PCR-based endpoint assessment
por: Varada, Jan C, et al.
Publicado: (2013)

Humoral response to SARS‐CoV‐2 and seasonal coronaviruses in COVID‐19 patients
por: Adams, Ortwin, et al.
Publicado: (2021)

A Recombinant Chimeric Cedar Virus-Based Surrogate Neutralization Assay Platform for Pathogenic Henipaviruses
por: Amaya, Moushimi, et al.
Publicado: (2023)

Immuno-Colorimetric Neutralization Test: A Surrogate for Widely Used Plaque Reduction Neutralization Tests in Public Health Virology
por: Vaidya, Sunil R.
Publicado: (2023)

Statistical evaluation of surrogate endpoints: a systematic review
por: Ensor, Hannah, et al.
Publicado: (2013)

Bivariate network meta‐analysis for surrogate endpoint evaluation
por: Bujkiewicz, Sylwia, et al.
Publicado: (2019)

Biomarkers and Surrogate Endpoints: Lessons Learned From Glaucoma
por: Medeiros, Felipe A.
Publicado: (2017)

Surrogate endpoints in trials: a call for better reporting
por: Ciani, Oriana, et al.
Publicado: (2022)

Development of a Neutralization Assay for Influenza Virus Using an Endpoint Assessment Based on Quantitative Reverse-Transcription PCR
por: Teferedegne, Belete, et al.
Publicado: (2013)

SARS-CoV-2 Infection in Fully Vaccinated Individuals of Old Age Strongly Boosts the Humoral Immune Response
por: Müller, Lisa, et al.
Publicado: (2021)

Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS-CoV-2 vaccination in kidney transplant recipients
por: Kantauskaite, Marta, et al.
Publicado: (2022)

Performance evaluation of newly developed surrogate virus neutralization tests for detecting neutralizing antibodies against SARS-CoV-2
por: Kweon, Oh Joo, et al.
Publicado: (2023)

Validation of a SARS-CoV-2 Surrogate Neutralization Test Detecting Neutralizing Antibodies against the Major Variants of Concern
por: Santos da Silva, Eveline, et al.
Publicado: (2023)

SARS-CoV-2 Neutralizing Responses in Various Populations, at the Time of SARS-CoV-2 Variant Virus Emergence: Evaluation of Two Surrogate Neutralization Assays in Front of Whole Virus Neutralization Test
por: Marot, Stephane, et al.
Publicado: (2022)

Body Temperature Drop as a Humane Endpoint in Snake Venom-Lethality Neutralization Tests
por: De Jesus, Rosa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rdoa5820umsilnjadg6ve9q0ve